93.5%
KPC pancreatic cancer4T1 triple-negative breast cancerresiquimodCD40 antibodyanti-CTLA4 antibodySTING agonist
…uated in murine models of 4T1 triple-negative breast cancer and KPC pancreatic cancer.Results The localized delivery of the five-drug combination in …